Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

6.13
-0.2100-3.31%
Post-market: 6.230.1000+1.63%19:30 EDT
Volume:835.40K
Turnover:5.21M
Market Cap:118.56M
PE:-1.01
High:6.68
Open:6.59
Low:6.06
Close:6.34
52wk High:20.56
52wk Low:6.06
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.12
T/O Rate:4.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.16
PE(LYR):-1.04

Loading ...

U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

Reuters
·
May 26

Corbus Pharmaceuticals Is Maintained at Outperform by Mizuho

Dow Jones
·
May 22

Mizuho Adjusts Price Target on Corbus Pharmaceuticals to $44 From $40, Maintains Outperform Rating

MT Newswires Live
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 22

Corbus Pharma director Brent Pfeiffenberger files initial beneficial ownership statement

Reuters
·
May 22

Corbus Pharmaceuticals Appoints First Chief Business Officer

TIPRANKS
·
May 21

Corbus Pharma names Nishant Saxena chief business officer

Reuters
·
May 21

Corbus Pharmaceuticals Holdings Inc - to Initiate Registrational Study for Crb-701 in Second-Line Hnscc This Summer

THOMSON REUTERS
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 Asco Crb-701 Data Conference Call

THOMSON REUTERS
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

GlobeNewswire
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
May 20

Corbus Pharmaceuticals Holdings Inc. Stock Falls 9.8%, Underperforms Peers

Dow Jones
·
May 19

Corbus Pharmaceuticals (CRBP) Receives a Buy from LifeSci Capital

TIPRANKS
·
May 16

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 15

Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates

TIPRANKS
·
May 14

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

THOMSON REUTERS
·
May 14

Corbus Pharmaceuticals Price Target Maintained With a $45.00/Share by Guggenheim

Dow Jones
·
May 13

Oppenheimer Adjusts Price Target on Corbus Pharmaceuticals to $54 From $57, Maintains Outperform Rating

MT Newswires Live
·
May 13